This summary was created by AI, based on 1 opinions in the last 12 months.
Solventum Corp (SOLV-N) has recently faced scrutiny due to a significant shift in its dividend policy. An expert mentioned that a client sold their shares not out of negativity towards the stock but due to this dividend cut following a corporate spin-off. However, on a more positive note, recent earnings reports from Solventum indicate that the company is performing decently in terms of profitability, and its valuation appears reasonable in the current market context. This suggests that while there may be short-term concerns related to income-focused investors, the underlying fundamentals could indicate long-term potential. Overall, the company might be experiencing transitional challenges but is not necessarily considered a poor investment based on its recent performance.
3m completed spinning off healthcare company Solventum today. MMM shares have been challenged by many lawsuits, including over its hearing aids, and some of its businesses have slowed. An exception is Solventum, positing positive organic growth over the past decade. Revenues were $8.2 billion in 2023, but guidance said that 2024 will be a rebuilding year. That said, it's now selling at 11x this year's earnings, cheap. Keep in mind that most spun-offs start off shaky, with those getting initial shares not wanting them. So, buy Solventum gradually over the next 6 months. As for 3M, they paid dearly to settle their lawsuits, so the worst is behind them. Also, they're cutting costs like crazy. Also, Wall Street likes the change in CEOs.
Solventum Corp is a American stock, trading under the symbol SOLV-N on the New York Stock Exchange (SOLV). It is usually referred to as NYSE:SOLV or SOLV-N
In the last year, 1 stock analyst published opinions about SOLV-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Solventum Corp.
Solventum Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Solventum Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Solventum Corp published on Stockchase.
On 2025-04-02, Solventum Corp (SOLV-N) stock closed at a price of $76.62.